glp-1 medicaid More states consider dropping weight loss drugs from • Stateline Medicare, Medicaid decline to cover

10.1038/s41598-018-28496-6 52 Sanchis-SeguraC.SpanagelR

Specifications Description Research Overview BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a partial sequence of human gastric juice protein

Compound Comparison Feature Class BPC-157 15-amino-acid synthetic pentadecapeptide TB-500 Synthetic 17-amino-acid Thymosin Beta-4 fragment Feature Common research focus BPC-157 Tendon, gut, vessel models

Vital Nutrients mission is to manufacture superior quality nutraceuticals that exceed both industry and government standards and provide clinically effective results

Gut-restricted peptide pharmacology Examined as a model of a locally-acting, minimally-absorbed oral peptide